Can reducing the dose of clonazepam (Klonopin) cause permanent hearing loss due to ringing in the ears?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Managing Tinnitus During Clonazepam Dose Reduction

Tinnitus (ringing in the ears) during clonazepam dose reduction is typically a withdrawal symptom that is unlikely to cause permanent hearing loss, but requires careful management to minimize discomfort and prevent complications.

Understanding Tinnitus During Benzodiazepine Withdrawal

  • Tinnitus can develop as a withdrawal symptom when tapering clonazepam, typically appearing within weeks of dose reduction 1
  • This symptom is considered part of the benzodiazepine withdrawal syndrome and is usually temporary rather than causing permanent hearing damage 1
  • Failure to take clonazepam can result in immediate relapse of symptoms, with rapid control restored after resumption of treatment 2

Risk Factors and Management

  • The persistence of tinnitus during withdrawal may prevent further dose reductions if not properly managed 1
  • Factors that increase risk of withdrawal symptoms include:
    • Rapid tapering schedule
    • Long-term use of clonazepam
    • Higher initial doses 3

Recommended Tapering Approach

  • A gradual tapering schedule is essential to minimize withdrawal symptoms including tinnitus 3
  • For patients on long-term clonazepam treatment, reduce dose by 0.25 mg per week after reaching 1 mg daily 3
  • Initial tapering can be done at 0.5 mg per 2-week period until reaching 1 mg daily, then slow to 0.25 mg weekly reductions 3

Monitoring During Tapering

  • Be vigilant for emergence of withdrawal symptoms including tinnitus, anxiety, trembling, insomnia, sweating, and palpitations 3
  • If tinnitus develops and becomes severe or persistent, consider temporarily pausing the taper or slowing the rate of reduction 1
  • Most withdrawal symptoms, including tinnitus, are mild when tapering is done gradually 3

Alternative Approaches

  • If tinnitus becomes problematic during tapering:
    • Consider temporarily stabilizing at current dose before continuing reduction 1
    • Melatonin (3-12 mg at bedtime) may be considered as an alternative therapy with fewer side effects 2
    • Individualize the tapering schedule based on symptom emergence 1

Important Distinctions

  • Tinnitus from benzodiazepine withdrawal differs from permanent drug-induced hearing loss seen with ototoxic medications like aminoglycosides, cisplatin, and loop diuretics 4
  • Unlike these medications that cause direct inner ear toxicity, benzodiazepine withdrawal tinnitus is typically reversible 1, 5

When to Seek Additional Care

  • If tinnitus persists beyond the expected withdrawal period (typically days to weeks) 1
  • If accompanied by significant hearing loss rather than just tinnitus 4
  • If symptoms are severe enough to significantly impact quality of life 1

Prognosis

  • With proper tapering, 68.9% of patients can successfully discontinue clonazepam within 4 months without major withdrawal symptoms 3
  • An additional 26% may need approximately 3 more months to completely discontinue the medication 3
  • Most withdrawal symptoms, including tinnitus, resolve with time after successful discontinuation or dose stabilization 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Drug-induced hearing loss.

Prescrire international, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.